BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Europe

Sparsentan Receives CHMP Endorsement for IgA Nephropathy Treatment in Europe

CSL Vifor together with Travere Therapeutics, Inc., disclosed that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CH...

February 26, 2024 | News

Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development

This latest phase involves development of an additional Optimer binder against the innovative Neuro-Bio target implicated in Alzheimer’s disease, wit...

February 23, 2024 | News

BioNTech's $200 Million Investment in Autolus Marks Milestone in Strategic CAR-T Collaboration, Revolutionizing Cancer Therapy

Strategic alliance leverages manufacturing and commercial infrastructure as well as technology with the aim to advance both...

February 08, 2024 | News

SOPHiA GENETICS Expands Program with AstraZeneca Spain to Enhance Access to HRD Testing Across Spain

Originally launched in 2022, the collaboration between SOPHiA GENETICS and AstraZeneca Spain established HRD testing in five labs across the countr...

February 08, 2024 | News

OGT expands NGS operations to state-of-the-art facility in Oxford Technology Park

OGT, a leading global provider of genomic research and diagnostic solutions, proudly announces the opening of state-of-the-art facilities within the Oxford...

February 08, 2024 | News

Genmab and Pfizer Announce European Medicines Agency Validation for Tisotumab Vedotin in Cervical Cancer

Genmab A/S (Nasdaq: GMAB) and Pfizer, Inc. (NYSE: PFE) have reported that the European Medicines Agency (EMA) has validated the marketing authorization app...

February 02, 2024 | News

WuXi Biologics Achieves Milestone with 16,000L Manufacturing Run in Ireland

First manufacturing run successful for MFG7 facility at the Ireland site Largest manufacturing scale to date achieved by combining four 4,000-liter sing...

February 01, 2024 | News

Nanoform Achieves Key Milestone in Clinical Trials for Enhanced Enzalutamide

These were from a relative bioavailability study of nanocrystalline-enabled enzalutamide (nanoenzalutamide) tablet formulation, an alternative to the amorp...

January 29, 2024 | News

Thermo Fisher's RNA Facility in Monza, Italy, Gains GMP Approval from Italian Medicines Agency (AIFA)

Thermo Fisher Scientific, the world leader in serving science, has received Good Manufacturing Practice (GMP) approval from the Italian Medicines Agency (A...

January 19, 2024 | News

Vetter Joins German Research-Based Pharma Association (vfa)

Association grants Vetter extraordinary membership vfa recognizes the importance of pharmaceutical service providers in drug development and production ...

January 18, 2024 | News

PulseAI's AI Algorithm Revolutionizes Consumer ECG Diagnostics

PulseAI, a leader in artificial intelligence healthcare solutions, announced a significant advancement in consumer device electrocardiogram (ECG) mon...

January 15, 2024 | News

Boehringer Ingelheim Invests EUR 120 Million in Greek Plant Expansion for Enhanced Medication Manufacturing and Job Creation

Main disease areas include cardio-renal-metabolic (CRM) diseases, mental health, pulmonary fibrosis, systemic sclerosis, and chronic liver disease, some of...

January 12, 2024 | News

Debiopharm and ThinkingNodeLife.ai Partner for AI-Boosted Cancer Drug Development

Debiopharm, an independent biopharmaceutical company headquartered in Switzerland, and ThinkingNodeLife.ai (TNL), a trailblazer in AI Digital Cells Lab in ...

January 10, 2024 | News

Evotec Advances Strategic Neuroscience Partnership with Bristol Myers Squibb

Evotec SE announced progress within the Company’s strategic partnership with Bristol Myers Squibb, further bolstering the joint pipeline of advanced ...

January 08, 2024 | News

Stay Connected